Specification
Description
Elimusertib, also known as BAY-1895344, is a potent and selective ATM inhibitor. BAY 1895344 shows potent anti-tumor efficacy in monotherapy and strong combination potential with the targeted alpha therapy Radium-223 dichloride.
Synonyms
Elimusertib, free base; BAY-1895344; BAY 1895344; BAY1895344
IUPAC Name
(R)-3-methyl-4-(4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl)morpholine
Canonical SMILES
CN1N=CC=C1C2=CC(N3[C@H](C)COCC3)=NC4=C(C5=CC=NN5)N=CC=C24
InChI
InChI=1S/C20H21N7O/c1-13-12-28-10-9-27(13)18-11-15(17-5-8-23-26(17)2)14-3-6-21-20(19(14)24-18)16-4-7-22-25-16/h3-8,11,13H,9-10,12H2,1-2H3,(H,22,25)/t13-/m1/s1
InChI Key
YBXRSCXGRPSTMW-CYBMUJFWSA-N
Solubility
To be determined
Shelf Life
>2 years if stored properly
Storage
Dry, dark and at 0-4 °C for short term (days to weeks) or -20 °C for long term (months to years).
Biological Target
Elimusertib (BAY-1895344) is a potent, orally active and selective ATR inhibitor with an IC50 of 7 nM.
Drug Formulation
To be determined
Elemental Analysis
C, 63.98; H, 5.64; N, 26.12; O, 4.26
HS Tariff Code
2934.99.9001
In Vitro Activity
BAY 1895344 also demonstrated very potent antiproliferative activity against various cancer cell lines in vitro, for example, in the CRC cell lines HT-29 (IC50: 160 nM) and LoVo (IC50: 71 nM) and in the B-cell lymphoma cell line SU-DHL-8 (IC50: 9 nM).
Reference: J Med Chem. 2020 Jul 9;63(13):7293-7325. https://pubmed.ncbi.nlm.nih.gov/32502336/
In Vivo Activity
In the model, treatment with BAY 1895344 applied at MTD demonstrated strong antitumor efficacy, whereas the ATR inhibitors AZD6738 and M6620 applied at MTD achieved only moderate antitumor efficacy (Fig. 1C).
Reference: Mol Cancer Ther. 2020 Jan;19(1):26-38. https://pubmed.ncbi.nlm.nih.gov/31582533/
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Stock Solution Storage
0-4 °C for short term (days to weeks), or -20 °C for long term (months).